Atlas FDA

TVL(TM) Lead System

FDA premarket approval P950022/S145 · decided 2024-03-18

Approval details

PMA number
P950022
Supplement
S145
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TVL(TM) Lead System
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
ABBOTT MEDICAL
Date received
2024-02-21
Decision date
2024-03-18
Days to decision
26 days
Decision code
OK30
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
Sylmar, CA
Statement
a change the manufacturing process and to add an alternate silver supplier used on HV leads wire materials

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18